Share:
An HIV prevention jab that provides six months of protection at a time was given the green light by South Africa’s medicines regulator. The approval helps to clear the way for a limited public sector rollout of the “game-changing” shot set to start in April 2026.
Read the full news story at Spotlight.
SEE ALSO:
- Bhekisisa: South Africa becomes the first African country to register the twice-a-year anti-HIV jab — at record speed
- South African Health Products Regulatory Authority (SAHPRA) press release: SAHPRA registers lenacapavir
- South African Government News Agency: South Africa becomes first African country to register groundbreaking anti-HIV injection lenacapavir
Source : Spotlight
Related HIV and Co-Infections News
-
WHO: Integrated drug resistance action framework for HIV, hepatitis B and C and STIs, 2026–2030
-
ECDC evidence brief: Progress towards earlier diagnosis of HIV and viral hepatitis in migrants and mobile populations in the EU/EEA
-
Gilead joins partners for delivery of first shipments of breakthrough twice-yearly lenacapavir for HIV prevention to sub-Saharan Africa
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.